SCHEMBL9697432

SCHEMBL9697432

CCCCCCCCCCCCCCCCOc1cc([N+](=O)[O-])ccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 6/20 0.62
SMPD1 P17405 1/20 0.54
CYSLTR2 Q9NS75 1/20 0.54
CYSLTR1 Q9Y271 1/20 0.54
CNR1 P21554 1/20 0.47
ACHE P22303 1/20 0.47
CNR2 P34972 1/20 0.47
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 1/20 0.46
THRA P10827 1/20 0.46
THRB P10828 1/20 0.46
TSHR P16473 2/20 0.45
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GPR35 Q9HC97 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699836 1.00 CYP19A1 (0.62) CYP19A1SMPD1CYSLTR2CYSLTR1CNR1
SCHEMBL29163212 1.00 CYP19A1 (0.62) CYP19A1SMPD1CYSLTR2CYSLTR1CNR1
SCHEMBL7695074 0.99 CYP19A1 (0.60) CYP19A1SMPD1CYSLTR2CYSLTR1CNR1
SCHEMBL5151538 0.94 CYP19A1 (0.54) CYP19A1SMPD1CYSLTR2CYSLTR1LMNA
SCHEMBL4233734 0.90 CYP19A1 (0.59) CYP19A1LMNAMAPTNPSR1ALDH1A1
SCHEMBL9699858 0.89 CYP19A1 (0.58) CYP19A1CYSLTR2CYSLTR1CNR1ACHE
SCHEMBL27719953 0.89 CYP19A1 (0.58) CYP19A1CYSLTR2CYSLTR1CNR1ACHE
SCHEMBL9165752 0.87 CYP19A1 (0.66) CYP19A1CYSLTR2CYSLTR1CNR1ACHE
SCHEMBL30292299 0.87 CYP19A1 (0.66) CYP19A1CYSLTR2CYSLTR1CNR1ACHE
SCHEMBL9127581 0.87 CYP19A1 (0.66) CYP19A1CYSLTR2CYSLTR1CNR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5147864-A Bronchodilator agent, antianaphylactic agent, antishock agent, cardiotonic agent and anticarcinogenic agent AMERICAN CYANAMID COMPANY (US) 1992-09-15 US disclosed
US-4983592-A Bis-arylphosphate ester antagonists of platelet activating factor AMERICAN CYANAMID CO. (US) 1991-01-08 US disclosed
EP-0374513-A2 Novel bis-arylphosphate ester antagonists of platelet activating factor AMERICAN CYANAMID COMPANY (US) 1990-06-27 EP disclosed